The novel endocannabinoid-like lipid N-arachidonoyl L-serine (ARA-S) causes vasodilation through both endothelium-dependent and -independent mechanisms. We have analyzed the vasorelaxant effect of ARA-S in isolated vascular preparations and its effects on Ca Endocannabinoids are endogenous fatty acid derivatives that bind to and activate the same receptors that recognize the plant-derived cannabinoid ⌬ 9 -tetrahydrocannabinol . Two G i/o -protein coupled cannabinoid receptors have been identified so far: the brain-type or CB 1 receptor, present at high levels in the brain and at lower levels in the peripheral tissues, and the CB 2 receptor, largely confined to immune and hematopoietic cells (Howlett, 2005) . In addition to their well known neurobehavioral effects, cannabinoids and their endogenous counterparts can influence other 
2ϩ
-activated K ϩ currents in human embryonic kidney cells stably transfected with the ␣-subunit of the human, large conductance Ca ϩ -activated K ϩ (BK Ca ) channel [human embryonic kidney (HEK) 293hSlo cells]. ARA-S caused relaxation of rat isolated, intact and denuded, small mesenteric arteries preconstricted with (R)-(Ϫ)-1-(3-hydroxyphenyl)-2-methylaminoethanol hydrochloride (pEC 50 , 5.49 and 5.14, respectively), whereas it caused further contraction of vessels preconstricted with KCl (pEC 50 , 5.48 and 4.82, respectively) . Vasorelaxation by ARA-S was inhibited by 100 nM iberiotoxin. In human embryonic kidney cells stably transfected with the ␣-subunit of the human BK Ca channel cells, ARA-S and its enantiomer, N-arachidonoyl-Dserine, enhanced the whole-cell outward K ϩ current with similar potency (pEC 50 , 5.63 and 5.32, respectively). The potentiation was not altered by the ␤ 1 subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, protein kinases, or Ca 2ϩ -dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution. BK Ca currents were also enhanced by N-arachidonoyl ethanolamide (pEC 50 , 5.27) but inhibited by another endocannabinoid, O-arachidonoyl ethanolamine (pIC 50 , 6.35 50 , 6 .59), which blocks ARA-S-induced vasodilation. We conclude the following. 1) ARA-S directly activates BK Ca channels. 2) This interaction does not involve cannabinoid receptors or cytosolic factors but is dependent on the presence of membrane cholesterol. 3) Direct BK Ca channel activation probably contributes to the endothelium-independent component of ARA-S-induced mesenteric vasorelaxation. 4) O-1918 is a BK Ca channel inhibitor.
), or by the synthetic cannabinoid O-1918 [(Ϫ)-1,3-dimethoxy-2-(3-3,4-trans-p-menthadien-(1,8)-yl)-orcinol] (pIC
Endocannabinoids are endogenous fatty acid derivatives that bind to and activate the same receptors that recognize the plant-derived cannabinoid ⌬ 9 -tetrahydrocannabinol . Two G i/o -protein coupled cannabinoid receptors have been identified so far: the brain-type or CB 1 receptor, present at high levels in the brain and at lower levels in the peripheral tissues, and the CB 2 receptor, largely confined to immune and hematopoietic cells (Howlett, 2005) . In addition to their well known neurobehavioral effects, cannabinoids and their endogenous counterparts can influence other physiological functions, including cardiovascular variables. In anesthetized animals, the endocannabinoid-arachidonoyl ethanolamide (anandamide) elicits hypotension primarily through CB 1 receptor-mediated cardiodepression (Bá tkai et al., 2004) . Anandamide also interacts with transient receptor potential vanilloid (TRPV) 1 receptors, although with a potency less than its potency at CB 1 receptors (Zygmunt et al., 1999) . In certain vascular beds, anandamide causes vasodilation, which does not involve activation of CB 1 , CB 2 , or TRPV1 receptors and has both endothelium-dependent and -independent components, the sensitivity of the former to pertussis toxin suggesting the involvement of a putative G i / G o -coupled receptor. The term "abnormal cannabidiol-sensitive receptor" has been coined, based on the similar vasodilator effect of this atypical synthetic cannabinoid ligand, which is not recognized by CB 1 , CB 2 , or TRPV1 receptors (Já rai et al., 1999) .
N-Arachidonoyl L-serine (ARA-S) is a novel, endogenous lipoamino acid present in the brain (Milman et al., 2006) , which can modulate neuronal-type Ca 2ϩ channels (Guo et al., 2008) . Chemically, ARA-S resembles anandamide but has no or very low affinity for CB 1 , CB 2 , or TRPV1 receptors. On the other hand, ARA-S induces vasodilation in rat isolated mesenteric arteries and aorta, which, similarly to the effects of anandamide or abnormal cannabidiol, has endothelium-dependent and -independent components (Milman et al., 2006) .
The endothelium-independent, pertussis toxin-resistant component of the vasodilator effect of anandamide has been linked to activation of the large conductance, calcium-activated potassium (BK Ca ) channel present in vascular smooth muscle (Plane et al., 1997) , independently of CB 1 , CB 2 , or TRPV1 receptors or anandamide metabolism (White et al., 2001 ). An electrophysiological study of anandamide-induced BK Ca currents suggests their dependence on undefined cytoplasmic factor(s) (Sade et al., 2006) . In blood vessels, BK Ca channels are expressed primarily in the smooth muscle cells, where they regulate vascular tone in response to changes in membrane potential, neurotransmitters, and cytosolic factors, e.g., calcium, protein kinases, and endothelium-derived hyperpolarizing factors (Brenner et al., 2000; Ghatta et al., 2006; Lu et al., 2006) .
We tested the hypothesis that ARA-S relaxes isolated rat mesenteric arteries by activating BK Ca channels. We also examined this mechanism in cells heterologously expressing the human BK Ca channel. Our findings indicate that ARA-S activates BK Ca channels, which likely accounts for its endothelium-independent vasorelaxant effect. In addition, we found the structural anandamide analog, O-arachidonoyl ethanolamine (virodhamine), and the atypical synthetic cannabinoid, O-1918, to be potent BK Ca channel inhibitors.
Materials and Methods
Vasomotor Response in Rat Isolated Mesenteric Arteries. Third-order segments of mesenteric arteries (200 -300 m in diameter) were isolated from male Sprague-Dawley rats (200 -300 g) and mounted in a wire myograph (Kent Scientific Corporation, Litchfield, CT), as described previously (Begg et al., 2003) . Concentrationresponse curves were constructed by cumulative addition of ARA-S to vessels precontracted with 5 M phenylephrine or 60 mM KCl. The functional integrity of the endothelium was verified by Ͼ90% relaxation elicited by 10 M acetylcholine. The endothelium was denuded by rubbing the inside of the artery with the mounting wire, resulting in the loss of acetylcholine-induced relaxation. Some vessels were pretreated with 100 nM iberiotoxin for 20 min before the experiment.
Cell Culture. Human embryonic kidney (HEK) 293 cells were from the American Type Culture Collection (Manassas, VA). HEK293 cells stably transfected with the cDNA encoding human BK Ca channel ␣-subunit splice variant, hbr1, derived from brain (HEK293hSlo) (Martin et al., 2004) were generously provided by Dr. Steven Treistman (University of Massachusetts, Worcester, MA). HEK293 cells were grown as monolayers on 25-cm 2 culture flasks in L-glutamine (292 g/ml), D-glucose (4.5 mg/ml), and sodium pyruvate (110 g/ml)-enriched Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA) containing 10% heat-inactivated fetal bovine serum, penicillin (100 IU/ml), and streptomycin (100 g/ml; Invitrogen). Selective pressure in HEK293hSlo cells was maintained by the presence of Geneticin (G-418, 500 g/ml; Invitrogen) in the medium. All cells were cultured at 37°C under a humidified atmosphere of 5% CO 2 . On the day of the experiment, cells were subcultured onto 35-mm plastic dishes and were allowed to adhere for 4 h before use. Before patch-clamp recording, the medium was replaced with external solution (ES). Patch Clamp. Experiments were performed as described earlier (Begg et al., 2003) , with modifications. Recording electrodes were pulled from borosilicate capillaries (TW150F-4; World Precision Instruments, Inc., Sarasota, FL) and fire polished to give resistances of 1.5 to 2.5 M⍀ (whole-cell mode and isolated outside-out patches) or 8 to 15 M⍀ (cell-attached mode). In whole cells and isolated outsideout patches, the electrodes were backfilled with internal solution (IS) of the following composition: 50 mM KCl, 70 mM KAsp, 8 mM NaCl, 1 mM MgCl 2 , 2 mM MgATP, 0.3 mM NaGTP, and 10 mM HEPES (adjusted to pH 7.2 with KOH; osmolarity, 305-315 mOsm/l). Unless stated otherwise, free intracellular calcium concentration ([Ca 2ϩ ] i ) was clamped at 1 M with 0.01 M 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) mixed with the appropriate amount of CaCl 2 . The composition of ES was as follows: 135 mM NaCl, 2.5 mM KCl, 1.0 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, and 2.5 mM CaCl 2 (adjusted to pH 7.4 with NaOH; osmolarity, 340 -350 mOsm/l). For single-channel recordings in the cell-attached mode, both ES and IS solutions contained 140 mM KCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose, pH 7.4 (osmolarity, 340 -350 mOsm/l). Chloride-coated silver wires connected the pipette IS to the probe input. The probe of the patch amplifier (Axopatch 1D; Axon Instruments) was mounted on a manipulator and connected through a digital interface (Digidata 1320A, Molecular Devices, Sunnyvale, CA) to a computer. The output signals were filtered with an eight-pole low-pass Bessel filter at 2 kHz (whole cells and isolated patches) or 3 kH (cell-attached mode) and digitized at 40 KHz. pCLAMP 9.1 software (Molecular Devices) was used for data acquisition and for off-line data analysis. All experiments were performed at room temperature.
Membrane currents were measured after Gigaseal formation (cellattached mode) and disruption of the cell membrane (whole-cell mode) or excision of membrane patches (outside-out patch mode). This process was monitored by applying a test pulse (5 mV, 5 ms, 100 Hz) to the cell, which allowed the analysis of series resistance and cancellation of capacitive transients. Cells were voltage clamped at a holding potential of Ϫ60 mV (whole-cell mode and isolated outsideout patches), or extracellular membrane potential of ϩ40 mV was applied (cell-attached mode). A series of depolarizing steps was generated in 10-mV increments to determine the conductance and current-voltage relationships. To test the effect of virodhamine and O-1918, the outward current was generated by a single 90-mV step in cells preincubated with ligands or their vehicles. To test the effect of ARA-S, anandamide, 2-arachidonoyl glycerol (2-AG), (Ϯ)11(12)-epoxy 5Z,8Z,14Z-eixosatrienoic acid (11, , and the BK Ca activator, NS 1619, on the BK Ca current, a single voltage step from the holding potential was applied before and after the application of the ligand or its vehicle. In preliminary experiments, each ligand was applied on the cell surface at the concentration of 3 or 10 M to establish the time course of drug action. The maximally effective exposure periods are provided in legends to the figures. The voltage step represented 20% of the peak current amplitude observed at ϩ60 mV (I max ) or 20% of the maximal conductance (G max ). The latter approach was used only when ARA-S was examined in the presence of ligands affecting the BK Ca channel current by themselves. For tail current analysis, a single test pulse of ϩ100 mV was applied, followed by increasing hyperpolarizing steps from ϩ30 to Ϫ170 mV in 10-mV increments.
Transient Transfection. HEK293hSlo cells were grown to 80 to 90% confluence in 35-mm Falcon tissue culture dishes coated with poly-D-lysine. Transient transfection was performed using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instruction. In brief, 2 l of Lipofectamine 2000 was mixed together with ϳ1 g of plasmid cDNA in 1 ml of serum-free minimal essential medium supplemented with L-glutamine and 4.5 g/l D-glucose (Invitrogen) and placed for 4 h in a humidified incubator containing 5% CO 2 at 37°C. DNA-containing medium was then aspirated and replaced with the regular cell culture medium. Electrophysiological recordings were typically performed 2 to 3 days after transfection. The blue light was used to excite green fluorescent protein to find transfected cells.
The plasmid construct containing the human ␤ 1 subunit was generously provided by Dr. Steven Treistman (University of Massachusetts). The fusion constructs used for membrane L-a-phosphatidyl-D-myoinositol-4,5-bisphosphate triammonium salt [PI(4,5)P 2 ] depletion were kindly provided by Dr. Tamas Balla (National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD).
Reverse Transcriptase-Polymerase Chain Reaction Analysis. Total RNA was isolated from cultured cells using TRIzol (Invitrogen) and then purified using RNase-free DNase with the RNeasy Set (QIAGEN, Valencia, CA). Purified RNA was reversetranscribed (RT) with the SuperScript First-Strand Synthesis System (Invitrogen). The resulting single-stranded cDNA was denatured for 2 min at 95°C and then subjected to 35 cycles of amplification, each consisting of 30 s at 95°C, followed by 30 s at 55°C and 3 min at 72°C, with a final 10-min extension step at 72°C during the last cycle. Fifty microliters of polymerase chain reaction (PCR) mixture contained the cDNA template (1 g), primer pair (each 1 M), and components of PCR SuperMix High Fidelity (45 l) (Invitrogen). The following forward versus reverse primer was designed to amplify a 259-bp segment of the human BK Ca channel ␣-subunit mRNA: 5Ј-ATATCCGCCCAGACACTGAC-3Ј versus 5Ј-GCACCGTGAAGAAATCCACT-3Ј. The human ␤-actin gene was amplified as a control. The PCR products were separated by electrophoresis on a 0.9% agarose gel (Invitrogen) in the presence of an 80-to 1000-bp DNA ladder (MBI Fermentas, Hanover, MD). RNA without reverse transcriptions did not yield any amplicons, indicating the absence of genomic DNA contamination.
Membrane Cholesterol Depletion and Repletion. Experiments were performed as described earlier (Westover et al., 2003) . In brief, HEK293hSlo cells were grown to subconfluence in 60-mm polystyrene culture dishes coated with poly-D-lysine. For cholesterol depletion, cells were incubated for 1 h at 37°C in serum-free DMEM containing 0.05 to 0.5% methyl-␤-cyclodextrin. To replace cholesterol, the medium was exchanged with serum-free DMEM containing 0.2 mM water-soluble cholesterol, and cells were incubated at 37°C for another hour under continuous mixing. Control cells were incubated in serum-free DMEM without methyl-␤-cyclodextrin and water-soluble cholesterol for 2 h. Differences in osmolarity among solutions were compensated with sucrose. Cells were thoroughly washed with ES before electrophysiological experiments.
Cholesterol Assay. Cells were washed twice with 1 ml of ice-cold phosphate-buffered saline, and lipids were extracted with 2 ml of hexane/isopropyl alcohol (3:2, v/v) for 1 h at room temperature. The organic extract was removed, and the solvent was evaporated under a stream of nitrogen. The lipid residue was solubilized in 20 l of 2-propanol and 10% Triton X-100, and free cholesterol was quantified by spectrophotometry at 562 nm (SpectraMax Plus 384; Molecular Devices, Sunnyvale, CA), according to the manufacturer's instructions (cholesterol/cholesteryl ester quantification kit; Calbiochem, San Diego, CA). After lipid extraction, the residual cell monolayer was solubilized for 15 min at 4°C with 1 ml of radioimmunoprecipitation assay lysis buffer (Santa Cruz Biochemicals, Santa Cruz, CA). The resulting lysate was transferred to a 1.5-ml Eppendorf tube and centrifuged at 10,000g for 10 min at 4°C. Protein content was determined in aliquots using the Bradford reagent (Sigma-Aldrich, St. Louis, MO).
Membrane PI(4,5)P 2 Depletion. HEKh293Slo cells were tripletransfected with the depletion constructs containing PH-GFP, FRB-CFP, and mRFP-FKBP12-5Pase (active construct) or mRFP-FKBP12 (inactive construct). Cells were incubated with 100 nM rapamycin for at least 3 to 5 min before the experiment to trigger the depletion of PI(4,5)P 2 in transfected cells (for details, see Varnai et al., 2006) .
Drugs. Rapamycin was purchased from BioSource International (Camarillo, CA). Arachidonic acid, URB597, ARA-S, anandamide, and virodhamine were from Cayman Chemical Co. (Ann Arbor, MI). NArachidonoyl-D-serine was synthesized as described previously (Milman et al., 2006) . 2-AG and 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE) were synthesized by Dr. J. R. Falck. 11,12-EET was from Tocris Bioscience (Ellisville, MO). PI(4,5)P 2 was from Calbiochem. O-1918 was synthesized as described previously by Begg et al., (2003) . 1-Aminobenzotriazole, 4-amino pyridine, staurosporine, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid (indomethacin), nordihydroguaiaretic acid (NDGA), iberiotoxin, NS 1619, pertussis toxin, (R)-(Ϫ)-1-(3-hydroxyphenyl)-2-methylaminoethanol hydrochloride (phenylephrine), BAPTA, methyl-␤-cyclodextrin, water-soluble cholesterol (powder, containing approximately 40 mg of cholesterol balanced with 1 g of methyl-␤-cyclodextrin), guanosine 5Ј-[␤-thio]-diphosphate (GDP-␤-S), NaGTP, and thapsigargin were from SigmaAldrich. For most drugs, stock solutions were prepared in dimethyl sulfoxide, with the exception of NS 1619, indomethacin, NDGA, anandamide, and virodhamine, which were dissolved in ethanol, and 1-aminobenzotriazole, 4-amino pyridine, iberiotoxin, 14,15-EEZE, phenylephrine, PI(4,5)P 2 , and rapamycin, which were dissolved in water. N-Arachidonoyl-L-serine was provided by the manufacturer as an ethanol solution.
Stock solutions were stored under nitrogen and diluted right before the experiment. The concentration of ethanol and dimethyl sulfoxide in the working solution did not exceed 0.05% (v/v). Solutions of methyl-␤-cyclodextrin and water-soluble cholesterol were prepared in serum-free DMEM. Cannabinoids were administered in the ES through a multichannel fast perfusion system, having an exchange time in the 100-ms range. Two millimolar GDP-␤-S and 100 M PI(4,5)P 2 were infused into the cell in the IS for 5 min before the recording was initiated.
, and 14,15-EEZE (20 M) were added to the ES for 30 min before recording, and pertussis toxin (1 g/ml) was added to the cell culture medium for 12 h before recording. The exposure times and concentrations of various modulators used in the present study have proven effective in other experimental designs (Jakab et al., 1997; Fukao et al., 2001; Begg et al., 2003; Dubey et al., 2003; Tarzia et al., 2003; Watanabe et al., 2003; Gauthier et al., 2005; Milman et al., 2006) . BAPTA was dissolved directly into the intracellular solution.
The online MaxChelator software (http://www.stanford.edu/ ϳcpatton/maxc.html) was used to calculate free [Ca 2ϩ ] i in the intracellular solution. Thus, free [Ca 2ϩ ] i was adjusted to 100 nM, 250 nM, 500 nM, 1 M, or 1.5 M by the administration to the IS of 1. 99, 3.32, 5.53, 7.30, or 8.35 mM CaCl 2 , respectively, in the presence of 0.01 M BAPTA. After each experiment, the superfusion apparatus was thoroughly washed with ethanol and distilled water to avoid any carryover of ligands.
N-Arachidonoyl L-Serine Activates BK Ca Channel
Statistical Analyses. For acquisition and analysis of myograph data, emka TECHNOLOGIES software (emka TECHNOLOGIES France, Paris, France) was used. Relaxant/contractile responses to ARA-S were expressed as a percentage of the phenylephrine/KClinduced tone.
The effects of ligands on the outward potassium current were expressed in absolute terms or as a ratio of the pretreatment control current amplitudes (I ligandc /I time0 ). A Boltzmann fit using the equa- 
a ], where y is the response, x is the drug concentration, C 50 is the concentration of drug producing 50% of the maximal effect, and a is the Hill coefficient.
Channel open probability (NP o ) in cell-attached mode was determined from 2-min recordings by fitting the sum of Gaussian functions to an all-points histogram plot. The NP o was defined as the time spent in an open state divided by the total time of the analyzed record. When multiple channels occupied a patch, channel activity was calculated as NP o ϭ ⌺nP n , where P n is the probability of finding n channels open.
General statistical data analysis was performed using Prism 4 (GraphPad Software Inc., San Diego, CA). Values are presented as means Ϯ S.E.M. Student's t test for unpaired or paired data were used for comparison of values between two groups as appropriate. For multiple comparisons, one-way analysis of variance followed by Dunnett test was used. Differences were considered significant when P Ͻ 0.05.
Results
Effect of ARA-S on Rat Mesenteric Artery. As illustrated in Fig. 1 , ARA-S relaxed rat isolated mesenteric arteries with intact endothelium precontracted with 5 M phenylephrine (pEC 50 , 5.49 Ϯ 0.18; n ϭ 6). The response to ARA-S was only slightly, but not significantly, affected by denudation (pEC 50 , 5.14 Ϯ 0.15; n ϭ 5). In both preparations, 100 nM iberiotoxin, a selective BK Ca channel inhibitor (Galvez et al., 1990) , produced marked rightward shifts of the ARA-S concentration-response curves (pEC 50 , 4.76 Ϯ 0.17 in intact and 4.61 Ϯ 0.13 in denuded arteries, P Ͻ 0.05 compared with respective controls; n ϭ 5-8). The increase in tone induced by phenylephrine did not differ between intact and denuded vessels (0.85 Ϯ 0.24 and 1.16 Ϯ 0.23 g, respectively; n ϭ 5-6) and was not affected by iberiotoxin (0.98 Ϯ 0.06 and 0.77 Ϯ 0.09 g, respectively; n ϭ 5-8). In contrast, ARA-S failed to relax arteries precontracted with 60 mM KCl and caused additional contractions in either intact or endothelium-denuded vessels (pEC 50 , 5.48 Ϯ 0.16 and 4.82 Ϯ 0.15, respectively; n ϭ 3; Fig. 1 ). The increase in tone produced by KCl was similar between treatment groups (0.53 Ϯ 0.04 and 0.56 Ϯ 0.03; n ϭ 3-4).
Characterization of Whole-Cell Outward Currents in HEK293hSlo Cells. Native HEK293 cells do not endogenously express BK Ca channels. Thus, the effects of endocannabinoids were studied in HEK293hSlo, as confirmed by RT-PCR (Fig. 2a) .
In HEK293hSlo cells held at Ϫ60 mV, a series of voltage steps produced a noninactivating, voltage-dependent, wholecell outward current, which was absent in native HEK293 cells. This current was completely blocked by 100 nM iberiotoxin ( Fig. 2b ) but was not affected by 5 M 4-amino pyridine, an inhibitor of voltage-gated potassium channels (Jiang et al., 2002) ; after the 90-mV step, the current was 93.2 Ϯ 9.3% of control in the presence of 4-amino pyridine (n ϭ 6). Analysis of the tail currents revealed a reversal potential of Ϫ87.6 Ϯ 2.5 mV (n ϭ 6; data not shown), similar to the predicted value for K ϩ using the Nernst equation being Ϫ97.5 mV. This indicates that K ϩ is the predominant ion carrying the outward current.
The magnitude of the whole-cell outward K ϩ current and the relative voltage-conductance relationship curves varied with the concentration of free [Ca 2ϩ ] i . Thus, the V 1/2 values were 117.2 Ϯ 2.6, 93.6 Ϯ 1.5, 67.3 Ϯ 1.6, and 43.3 Ϯ 1.9 mV (n ϭ 6; P Ͻ 0.05), when free [Ca 2ϩ ] i was clamped at 0.1, 0.5, 1.0, and 1.5 M, respectively, with corresponding k values of 21.55 Ϯ 3.14, 21.71 Ϯ 1.92, 16.65 Ϯ 1.78, and 16.82 Ϯ 2.90, respectively (data not shown). In most experiments, free [Ca 2ϩ ] i was fixed at 1 M. The peak whole-cell outward K ϩ current at ϩ60 mV (I max ) was similar among cells tested on the same day but varied from 389.9 Ϯ 49.3 to 861.5 Ϯ 62.2 pA/pF (n ϭ 4 -6; P Ͻ 0.001) on a day-to-day basis. To test the effect of endocannabinoids and related ligands, a voltage step that represented 20% of I max was applied to cells. This voltage ranged from 86.5 Ϯ 0.8 to 94.0 Ϯ 2.5 mV (n ϭ 5-6) in different batches of cells. For consistency, the expression "ϳ90-mV step" will be used throughout the article to cover the above range, whereas "90-mV step" will be used when experiments were performed exactly at this step.
Effects of ARA-S on the Whole-Cell Outward K ؉ Current in HEK293hSlo Cells. Application of 3 M ARA-S markedly enhanced the whole-cell outward K ϩ current, and it was still nearly completely blocked by 100 nM iberiotoxin. The effect of ARA-S reached a maximum within 15 to 30 s and was rapidly reversed upon removal of the drug (Fig. 2c) . In the presence of the selective BK Ca channel opener NS 1619, ARA-S further increased this current, and it remained sensitive to iberiotoxin (Fig. 2c) .
As shown in Fig. 2d , ARA-S enantiomers increased BK Ca (Fig. 2d) . Because N-arachidonoyl L-serine was earlier described as an endogenous lipid in the porcine brain (Milman et al., 2006) , the effects of this enantiomer will be described in the remainder of this study. Application of ARA-S caused a concentration-dependent leftward shift of the relative voltage-conductance relationship curves. The V 1/2 values were 58.6 Ϯ 2.0, 49.3 Ϯ 1.5, and 40.0 Ϯ 1.8 mV in cells exposed to vehicle and 3 and 10 M ARA-S, respectively (n ϭ 6; P Ͻ 0.001). The corresponding k values were 18.4 Ϯ 2.7, 17.5 Ϯ 2.3, and 15.9 Ϯ 2.4 (data not shown).
In control cells, activation time constants measured from single exponential fits to the 100-mV depolarization step averaged 4.3 Ϯ 0.5 ms (n ϭ 7) and remained unchanged after exposure to 3 and 10 M ARA-S (3.9 Ϯ 0.2 and 3.7 Ϯ 0.1 ms, respectively; n ϭ 6 -7; Fig. 2e ). The current deactivation time constant was quantified by single exponential fits to the decaying phase of the tail current by a step from ϩ40 to Ϫ130 mV. In control cells, the decay time constant was 0.19 Ϯ 0.01 ms (n ϭ 7) and was also unaffected in the presence of either ARA-S concentrations (0.17 Ϯ 0.01 and 0.21 Ϯ 0.01 ms, respectively; n ϭ 6 -7; Fig. 2e) .
The current density generated by the 90-mV depolarization step from the holding potential did not significantly differ between cells infused via the patch pipette with 10 M ARA-S (269.3 Ϯ 56.6 pA/pF; n ϭ 6) or its vehicle (174.7 Ϯ 27.0 pA/pF; n ϭ 6). The presence of 10 M ARA-S inside the cell did not alter the magnitude of the response to 3 M ARA-S applied on the extracellular cell surface (respective I ARA-S / I time0 values were 1.44 Ϯ 0.04 and 1.51 Ϯ 0.04 in cells pretreated with 10 M ARA-S or vehicle via patch pipette; n ϭ 6).
Effects of ARA-S on the Outward K ؉ Current in HEK293hSlo Cells Cotransfected with the ␤ 1 Subunit. The presence of the ␤ 1 subunit in HEK293hSlo cells (HEK293hSlo␤ 1 ) produced a leftward shift in the relative voltage-conductance relationship curve (Fig. 3a) , decreasing the respective V 1/2 values from 47.2 Ϯ 3.1 to 34.8 Ϯ 1.9 mV (P Ͻ 0.001; n ϭ 5-6; the k values under the same conditions were 16.2 Ϯ 2.5 and 15.9 Ϯ 1.6). As a consequence, the voltage step was also adjusted from 89.8 Ϯ 1.1 to 76.2 Ϯ 1.7 mV to produce a K ϩ current of 2.28 Ϯ 0.08 and 2.34 Ϯ 0.05 figure) on the wholecell outward K ϩ current generated by the ϳ90-mV step. Cells were exposed to ARA-S enantiomers for 15 s. The current amplitude in cells treated with the vehicle was taken as unity (dashed line). n ϭ 4 -7; ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with the vehicle-treated cells; #, P Ͻ 0.05, ##, P Ͻ 0.01 compared with the ARA-S L-enantiomer. Original traces correspond to the current stimulated by the ϳ90-mV step. e, sample traces of the outward potassium current during the depolarization step (left) and repolarization step (right) produced by tail current protocol in the presence of 10 M ARA-S or its vehicle. nA, respectively (n ϭ 5-6), corresponding to 0.2 G max . As shown in Fig. 3b , the response to ARA-S was not altered by the ␤ 1 subunit. The amplitude of the K ϩ current in HEK293hSlo␤ 1 cells after ARA-S application was sensitive to 100 nM iberiotoxin (inhibition by 85.0 Ϯ 3.7%; P Ͻ 0.001; n ϭ 3; see also Fig. 3b) .
N-Arachidonoyl
Effects of ARA-S on the Outward K ؉ Current in Whole Cells, Cell-Attached Mode, and Outside-out Patches Obtained from HEK293hSlo Cells. A series of voltage steps produced a noninactivating voltage-dependent macroscopic outward K ϩ current in excised outside-out patches, which was of much smaller amplitude than that observed in whole-cell recordings, but had similar V 1/2 value of the relative conductance-voltage relationship curves (72.5 Ϯ 1.3 and 71.9 Ϯ 3.2 mV, respectively; n ϭ 3-5; Fig. 4a ). The corresponding k values for the recording at different configurations were 14.9 Ϯ 5.5 and 17.5 Ϯ 1.6. As shown in Fig. 4b , the sensitivity of excised patches to ARA-S was reduced relative to whole cells (P Ͻ 0.01 for ratios I ARA-S / I vehicle at every time point). Thus, the excised patches were not sensitive to 3 M ARA-S and produced maximally 42.1 Ϯ 4.0% (n ϭ 6) of the potentiation observed in whole cells when exposed to 10 M ARA-S. In contrast, 10 M NS 1619 was equally effective in the two recording configurations (Fig. 4b) .
Application of ARA-S in cell-attached mode followed the same pattern as in isolated patches (Fig. 4c) . The NP o in cells before treatment was 0.035 Ϯ 0.007 (n ϭ 12). This value was not significantly altered by 3 M ARA-S but increased 2-fold by 10 M ARA-S by increasing the frequency of channel openings (from 159.78 Ϯ 30.28 to 204.46 Ϯ 31.10 Hz, P Ͻ 0.05; n ϭ 4) and time spent in an open state (peak half width; from 0.75 Ϯ 0.04 to 0.83 Ϯ 0.05 ms; P Ͻ 0.05; n ϭ 4). The response was sensitive to iberiotoxin (Fig. 4c) . The current amplitude did not differ among cells treated for 2 min with vehicle and 3 to 10 M ARA-S (9.20 Ϯ 0.17, 9.23 Ϯ 0.11, and 9.31 Ϯ 0.09, respectively; n ϭ 4).
G Proteins, Cytosolic Factors, and Free [Ca

2؉
] i Are Not Involved in the Effects of ARA-S. The potentiation of the whole-cell K ϩ current by ARA-S was not affected by the irreversible G protein inhibitor GDP-␤-S, specific G i/o protein inhibitor pertussis toxin, or by the broad-spectrum protein kinase inhibitor staurosporine (Table 1) . Likewise, the epoxyeicosatrienoic acid antagonist 14,15-EEZE, cyclooxygenase inhibitor indomethacin, lipoxygenase inhibitor NDGA, fatty acid amide hydrolase inhibitor URB597, and cytochrome P-450 inhibitor 1-aminobenzotriazole were without effect on the response of HEK293hSlo cells to ARA-S (Table 1) .
Clamping free [Ca 2ϩ ] i at 100 nM, 500 nM, 1 M, and 1.5 M required different absolute voltages (140.8 Ϯ 2.2, 120.0 Ϯ 2.1, 105.7 Ϯ 2.1, and 88.8 Ϯ 1.9 mV, respectively; n ϭ 4 -6) to produce whole-cell outward K ϩ current (1.9 Ϯ 0.1, 2.5 Ϯ 0.1, 2.4 Ϯ 0.2, and 2.2 Ϯ 0.1 nA) equivalent to 0.2 G max . With the exception of the lowest [Ca 2ϩ ] i , application of 3 M ARA-S caused a similar potentiation of K ϩ current at all other [Ca 2ϩ ] i concentrations (the respective I ARA-S /I time0 values were 1.96 Ϯ 0.04, 1.71 Ϯ 0.06, 1.68 Ϯ 0.04, and 1.66 Ϯ 0.02; n ϭ 4 -6; P Ͻ 0.01, according to one-way analysis of variance). In addition, pretreatment of HEK293hSlo cells for 30 min with the sarcoplasmic reticulum ATPase inhibitor 1 M thapsigargin did not affect the whole-cell outward K ϩ currents induced by the 90-mV depolarization step (2.1 Ϯ 0.4 nA with vehicle and 2.0 Ϯ 0.3 nA with thapsigargin; n ϭ 4 -5) or its potentiation by 3 M ARA-S (the respective I ARA-S /I time0 values were 1.71 Ϯ 0.06 and 1.69 Ϯ 0.07 in vehicle-and thapsigargin-pretreated cells; data not shown).
The Effect of Cholesterol Depletion/Repletion on the ARA-S Response. Incubation of HEK293hSlo cells with the cholesterol depleting agent methyl-␤-cyclodextrin did not affect the current-voltage relationship curves. The basal current generated by the ϳ90-mV step from holding potential was 2.17 Ϯ 0.21 nA in the control group (n ϭ 9) and 2.46 Ϯ 0.13, 2.34 Ϯ 0.23, 2.54 Ϯ 0.27, and 1.93 Ϯ 0.24 nA in cells treated with increasing concentrations of methyl-␤-cyclodextrin (n ϭ 3-9; see original recording, Fig. 5 ). Methyl-␤-cyclodextrin inhibited the ARA-S enhancement of whole-cell outward K ϩ currents in a concentration-dependent manner (Fig. 5) . Complete inhibition of the ARA-S effect occurred at 0.5% (3.8 mM) methyl-␤-cyclodextrin. In contrast, 0.5% methyl-␤-cyclodextrin did not affect the response to 10 M NS 1619 (the I 120s /I time0 values were 3.37 Ϯ 0.24 and 3.26 Ϯ 0.22 in the control and methyl-␤-cyclodextrin pretreated cells, respectively; n ϭ 5). As shown earlier (Sarker and Maruyama, 2003) , methyl-␤-cyclodextrin at concentrations up to 5 mM had no toxic effect on the cell. Repletion of cholesterol to previously depleted membranes by exposure to 0.2 mM water-soluble cholesterol restored the response to ARA-S (Fig.   5) . Changes in the current potentiation by ARA-S after cholesterol depletion and reconstitution correlated with the changes in cellular cholesterol content (Table 2) . ϩ current in isolated outside-out patches and in whole cells. The current was generated by the ϳ90-mV step from a holding potential of Ϫ60 mV before (time 0) and after application of ligand or its vehicle. n ϭ 3-6. c, effect of ARA-S on the BK Ca channel activity in cell-attached mode. Cells were voltage clamped at a holding potential of ϩ40 mV. ARA-S or its vehicle was applied on the cell surface. Iberiotoxin was present in the pipette for 2 min. Each point represents four experiments. Traces are representative of 250-ms recording obtained 2 min after ARA-S application. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with cells treated with the vehicle. Membrane PI(4,5)P 2 Alters the Whole-Cell K ؉ Current in HEK293hSlo Cells but Does Not Affect the Response to ARA-S. As shown earlier (Varnai et al., 2006) , rapamycin at the concentration of 100 nM triggers an immediate depletion of PI(4,5)P 2 in transfected cells. In the present study, rapamycin treatment caused a small but significant rightward shift of the relative voltage-conductance relationship curve in HEK293hSlo cells transfected with the active PI(4,5)P 2 -depletion construct. The V 1/2 values were 49 Ϯ 1.9 and 56.9 Ϯ 1.1 mV (P Ͻ 0.001; n ϭ 5-6), and the corresponding k values were 17.2 Ϯ 1.6 and 19.1 Ϯ 0.8 in cells transfected with the inactive (control) and active depletion constructs, respectively. The magnitude of the response to 3 M ARA-S did not differ between constructs (I ARA-S /I time0 values were 1.54 Ϯ 0.04 and 1.46 Ϯ 0.05, respectively; n ϭ 5-6; data not shown).
Infusion of 100 M PI(4,5)P 2 into the cell only tended to shift the relative voltage-conductance relationship curve to the left. The V 1/2 values were 82.7 Ϯ 1.5 and 78.8 Ϯ 1.1 mV (n ϭ 6), and the corresponding k values were 14.7 Ϯ 1.2 and 18.7 Ϯ 1.8 in cells treated with vehicle and PI(4,5)P 2 , respectively. Infusion of PI(4,5)P 2 to the cell did not alter the response to 3 M ARA-S (I ARA-S /I time0 ratios were 1.59 Ϯ 0.03 and 1.51 Ϯ 0.04, respectively; n ϭ 6; data not shown).
Effect of Ligands Structurally Related to ARA-S on the Whole-Cell Outward K ؉ Current in HEK293hSlo Cells. Anandamide increased the whole-cell outward K ϩ current in a concentration-dependent fashion (pEC 50 of 5.32 Ϯ 0.24; n ϭ 4 -6; Fig. 6a ). The efficacy of the response to anandamide was significantly lower than for ARA-S (I ligand / I control ratio was 2.31 Ϯ 0.32 and 2.31 Ϯ 0.15, respectively; P Ͻ 0.01; n ϭ 4 -6; for comparison, see also Figs. 2d and 6a) . In contrast, arachidonic acid was less potent than ARA-S (pEC 50 was 4.78 Ϯ 0.19; P Ͻ 0.05; n ϭ 3; Fig. 6a ) but had similar maximal effect (I ligand /I control ratio was 3.54 Ϯ 0.38; for comparison, see also Figs. 2d and 6a). 2-AG and the epoxylated derivative of arachidonic acid, 11,12-EET, were inactive in the present study up to 10 M (Fig. 6a) . Incubation of cells with virodhamine inhibited the whole-cell outward K ϩ current in HEK293hSlo cells (pIC 50 value of 6.35 Ϯ 0.16; n ϭ 3-5; Fig. 6b ). The inhibitory effect also occurred in outside-out patches exposed to 10 M virodhamine (inhibition by 60.0 Ϯ 7.0%, P Ͻ 0.05 compared with control; n ϭ 8; data not shown).
Effects of O-1918 on Outward K ؉ Current. The synthetic cannabinoid analog O-1918 inhibited the whole-cell outward K ϩ current in HEK293hSlo cells with a pIC 50 value of 6.59 Ϯ 0.16 (n ϭ 3-6; Fig. 6b ). The inhibitory effect of O-1918 was also reflected by the rightward shift of the V 1/2 values of the relative conductance-voltage curve (from 59.6 Ϯ 1.4 mV in the presence of vehicle to 65.5 Ϯ 3.6, 82.0 Ϯ 1.2, 92.9 Ϯ 2.6, 127.5 Ϯ 5.7, and 132.8 Ϯ 8.2 mV in the presence of 0.1-10 M O-1918) and no changes in k values. The wholecell outward potassium current of 2.26 Ϯ 0.06 (n ϭ 12), corresponding to 0.2 G max , was generated in the presence of 1 M O-1918 or its vehicle as a control by a voltage step of 121.5 Ϯ 2.6 (n ϭ 6) and 92.7 Ϯ 1.2 (n ϭ 6) mV, respectively. Application of 3 M ARA-S increased this current by 90.7 Ϯ 4.9% (n ϭ 6) in control cells and by 55.1 Ϯ 1.9% (n ϭ 6) in the presence of 1 M O-1918 (inhibition by approximately 40%; P Ͻ 0.001 compared with the control). O-1918 (1 M) also effectively inhibited the current in outside-out patches stimulated by the 90-mV step (inhibition by 85.4 Ϯ 1.5%; P Ͻ 0.001; n ϭ 3; data not shown).
Discussion
The present findings provide evidence that the recently identified endogenous lipoamine ARA-S is an activator of BK Ca channels, which accounts for its vasodilator action. In phenylephrine-preconstricted rat mesenteric arteries, ARA-S produced largely endothelium-independent vasorelaxation, which was inhibited by iberiotoxin, implicating the involvement of vascular BK Ca channels. Moreover, ARA-S caused vasoconstriction when vessels were preconstricted with KCl, which further supports its vasorelaxant effect through K ϩ channels. In some preparations, ARA-S has been shown previously to have endothelium-dependent and -independent vasorelaxant components, both sensitive to O-1918 O- (Milman et al., 2006 , suggesting that this synthetic cannabinoid may also target smooth muscle channels. Indeed, as discussed below, O-1918 is a potent inhibitor of BK Ca -gated K ϩ currents. CB 1 receptors mediate vasorelaxation in some vessels by increasing the activity of BK Ca channels (Romano and Lograno, 2006) . However, ARA-S does not bind to CB 1 receptors, and its effect is resistant to pertussis toxin (Milman et al., 2006) , which resembles the BK Ca channel-dependent, CB 1 /CB 2 receptor-independent vasorelaxation by anandamide in rat mesenteric (Plane et al., 1997; Já rai et al., 1999) and coronary (White et al., 2001) arteries.
Additional evidence for BK Ca channels being a direct molecular target of ARA-S is the ability of ARA-S to potentiate BK Ca currents in HEK293hSlo cells. The presence of the functional BK Ca channel ␣ subunit in HEK293hSlo cells was confirmed by RT-PCR and by the sensitivity of the outward current to voltage, [Ca 2ϩ ] i , the selective BK Ca channel opener NS 1619 (Olesen et al., 1994) , and the BK Ca inhibitor iberiotoxin (Galvez et al., 1990) . Although native voltage-gated K ϩ channels are present in HEK293 cells (Jiang et al., 2002) , the peak current amplitude was not modified by 4-amino pyridine, ruling out their contribution to the total current. To mimic smooth muscle type BK Ca channels, HEK293hSlo cells were cotransfected with the human BK Ca ␤ 1 subunit, which resulted in the expected increase in voltage sensitivity (Brenner et al., 2000) . Because potentiation of the BK Ca current by ARA-S was similar in the absence of presence of the ␤ subunit, the ␣ subunit itself is its most likely target.
Similar effects of L-and D-enantiomers of ARA-S indicate the lack of stereoselectivity, which discounts the involvement of specific receptor. As an alternative, an indirect action via membrane lipids is suggested by the loss of ARA-S response after membrane cholesterol depletion and its restoration after cholesterol replenishment. The external membrane event is substantiated by the fact that intracellular application of ARA-S inside the patch pipette did not significantly alter BK Ca channel activity and did modify the effect of ARA-S applied on the extracellular cell surface.
Mechanism of Channel Potentiation by ARA-S. ARA-S potentiated the BK Ca current only when it was applied extracellularly in the whole-cell mode by shifting the voltage-conductance relationship toward more negative potentials. The activation and deactivation time constants were unaffected, suggesting that ARA-S does not directly interact with the gating mechanism of the channel pore. The response to 3 M ARA-S is reduced in excised patches relative to the whole-cell configuration. This decrease cannot be because of changes in basic channel properties because the BK Ca conductance and the response to NS 1619 remained unchanged. A similar weaker effect was observed when ARA-S was applied to the cell surface in cell-attached mode, suggesting that the compound acts locally. ARA-S augmented the BK Ca current by increasing the channel open probability, similar to the mechanism proposed for the BK Ca channel opener NS 1619 (Olesen et al., 1994; Khan et al., 1998) . However, NS 1619 did not modify the effect of ARA-S, suggesting that the two compounds interact with distinct sites on the channel.
The cellular metabolism of ARA-S has not yet been explored. We have considered ARA-S to be a putative substrate for fatty acid amide hydrolase, cyclooxygenase, lipoxygenase, and cytochrome P-450, by analogy to anandamide (Watanabe et al., 2003) , arachidonic acid (Fukao et al., 2001) , and other fatty acids (Duerson et al., 1996) . In particular, cytochrome P450 epoxygenase-derived eicosanoids have been shown to increase BK Ca channel activity in HEK293 cells (Fukao et al., 2001 ) and produce BK Ca channel-dependent vasorelaxation through specific mechanisms (Gauthier et al., 2005) . However, application of potent inhibitors failed to modify ARA-S potentiation of the BK Ca channel, suggesting that its effect is because of the parent compound rather than a metabolite.
Potentiation of BK Ca currents by ARA-S does not involve G protein activation because it remained unaffected by the specific G i/o protein inhibitor pertussis toxin or by GDP-␤-S, a nonequilibrium inhibitor of all G proteins. The lack of effect of the broad-range kinase inhibitor, staurosporine, argues against the involvement of kinase-dependent downstream signaling molecules, e.g., mitogen-activated protein kinase, protein kinase B, and cAMP-and cGMP-dependent protein kinases, which are known to modulate BK Ca currents in certain systems (Zhou et al., 2001; O'Malley and Harvey, 2004; Liu et al., 2006) and in endothelial cells (Milman et al., 2006) .
The effect of ARA-S in HEK293hSlo cells was largely independent of changes in [Ca 2ϩ ] i . Only when [Ca 2ϩ ] i was clamped at 100 nM was a more pronounced response to ARA-S observed. This may indicate that cellular sensitivity to ARA-S is higher at resting [Ca 2ϩ ] i levels and might explain the reported higher potency of anandamide (Sade et al., 2006) jpet.aspetjournals.org BK Ca channels with sarcoplasmic reticulum (Weaver et al., 2007) could also not account for the effect of ARA-S because it was not modified by the sarcoplasmic reticulum ATPase inhibitor thapsigargin. Endocannabinoids approach their site of action by interacting with the lipid bilayer and laterally diffusing within the membrane leaflet to the target protein (Makriyannis et al., 2005) . To test whether membrane components play a role in the action of ARA-S, we experimentally altered membrane cholesterol levels. Reduction of membrane cholesterol by treatment with methyl-␤-cyclodextrin resulted in a loss of response to ARA-S, which could be restored by cholesterol reconstitution. Methyl-␤-cyclodextrin treatment did not change the current-voltage relationship or the response to NS 1619, arguing against altered channel properties as the underlying mechanism. The loss of some cytosolic factors during cholesterol depletion is also unlikely because the reconstitution of pure cholesterol into the membrane completely restored the sensitivity of BK Ca channels to ARA-S. Therefore, it is plausible that the state of the plasma membrane plays a crucial role in the ARA-S effect, most likely by allowing the lipophilic arachidonoyl side chain to anchor to the lipid membrane and to access the channel protein. Alternatively, ARA-S may alter cell membrane properties and thus secondarily affect BK Ca channel function. As shown by O'Connell et al. (2006) , channel electrophysiological properties are affected by lipid bilayer composition.
The loss of the ARA-S effect in cholesterol-depleted cells parallels the rundown of the ARA-S response after patch excision. It is possible that some membrane lipid factors may be disturbed during patch excision. The membrane phospholipid PI(4,5)P 2 is a known regulator of ion channel function (Oliver et al., 2004; Lukacs et al., 2007) , but it is not involved in the effect of ARA-S on BK Ca currents, which remained unaffected by depleting or adding PI(4,5)P 2 to the preparation.
To explore the structural requirements of BK Ca activation by ARA-S, the effect of ligands structurally related to ARA-S were analyzed in the present study. Thus, arachidonic acid was 10 times less potent than ARA-S, whereas 11,12-EET was inactive. Anandamide was equipotent with ARA-S, but its efficacy was much lower. The presence of an ethanolamine moiety in anandamide seems to be critical because its replacement with glycerol (2-arachidonoyl glycerol) resulted in the loss of effect. Interestingly, virodhamine potently inhibited the BK Ca current, and its inhibitory effect persisted in isolated patches. The nature of channel modulation by above ligands and particularly whether they share a similar mechanism to that of ARA-S still requires further investigation.
The present data indicate that the endothelium-independent component of ARA-S-induced vasodilation is because of the activation of BK Ca channels and that O-1918 is an inhibitor of BK Ca -gated K ϩ currents. A similar direct interaction may also account for the activation by ARA-S of N-type Ca 2ϩ channels (Guo et al., 2008) . Our findings do not negate the possibility that the endothelium-dependent, pertussis toxinsensitive component of the effect of ARA-S and anandamide, as reported in numerous earlier studies (Já rai et al., 1999; Mukhopadhyay et al., 2002; Randall et al., 2004; Milman et al., 2006) , may be mediated by an as yet unidentified G protein-coupled receptor.
